Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001051164 | SCV001215305 | pathogenic | Autosomal recessive limb-girdle muscular dystrophy type 2D | 2019-02-21 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Gly265Glnfs*57) in the SGCA gene. It is expected to result in an absent or disrupted protein product. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals with SGCA-related conditions. Loss-of-function variants in SGCA are known to be pathogenic (PMID: 9192266). For these reasons, this variant has been classified as Pathogenic. |
Laboratory of Inherited Metabolic Diseases, |
RCV001051164 | SCV001432997 | pathogenic | Autosomal recessive limb-girdle muscular dystrophy type 2D | 2020-02-11 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001051164 | SCV003931702 | pathogenic | Autosomal recessive limb-girdle muscular dystrophy type 2D | 2023-02-08 | criteria provided, single submitter | clinical testing |